By The CCM Team
Every therapy, drug or approach that is in place today to treat cancer had its start in a clinical trial. Florida Cancer Specialists (FCS) teams up with Sarah Cannon Research Institute, the research arm of HCA’s global cancer institute and one of the world's leading clinical research organizations, to bring innovative treatment options to patients throughout Florida.
With a shared focus on clinical excellence and cutting-edge research, Sarah Cannon and FCS have enrolled more than 6,000 patients on innovative studies to find more effective treatments for many types of cancer.
Researchers say the process of bringing more effective drugs to the marketplace could advance even more quickly if more people took part in the investigational studies. But they acknowledge several obstacles, including the general public’s lack of awareness and misinformation about this key aspect of the drug-approval process.
For this Cancer 360-Plus magazine feature, writer Mark Zaloudek sat down with Dr. James Reeves, FCS director of research operations, and Katie Goodman, FCS director of clinical research, for a frank discussion that resulted in a brief true/false quiz that will dispel some common misunderstandings of clinical trial research.